How many drugs were approved in 2018?

Drug Landscape tracks 75 drug approvals with a first_approval_date in 2018 (FDA, EMA, MHRA, PMDA combined). The full list is on this page, each linked to its primary regulatory source.

Which patents expired in 2018?

No tracked patents have an expiry date in 2018.

What Phase 3 readouts happened in 2018?

No Phase 3 trials have completion dates in 2018.

Where does this data come from?

Approvals from FDA Drugs@FDA, EMA EPAR, MHRA, and PMDA. Patent data from FDA Orange Book + USPTO PAIR. Trial data from ClinicalTrials.gov. Updates daily.

2018 in pharma — approvals, patent cliffs, Phase 3 readouts

Every FDA approval, patent expiry, and pivotal Phase 3 readout tracked for 2018: 75 approvals, 0 patent expiries, 0 Phase 3 milestones.

2016 2017 2018 2019 2020

FDA / EMA / MHRA approvals (75)

2019 — Enhertu · Daiichi Sankyo · Oncology
2019 — Ibsrela · Ardelyx Inc · Metabolic
2019 — Fluorodopa F18 · Feinstein · Neuroscience
2019 — Vyndaqel · Foldrx Pharms · Neuroscience
2019 — Exem Foam Kit · Giskit · Other
2019 — Brukinsa · BeiGene
2019 — Trikafta (Copackaged) · Vertex Pharms Inc · Respiratory
2019 — Vumerity · Biogen · Immunology
2019 — Vyndaqel · Foldrx Pharms · Neuroscience
2019 — Vyndaqel · Foldrx Pharms · Neuroscience
2019 — Nuceiva · GlaxoSmithKline K.K. · Neuroscience
2019 — ESKETAMINE HYDROCHLORIDE
2019 — TRASTUZUMAB DERUXTECAN
2019 — Fluorodopa F18 · Feinstein · Neuroscience
2019 — Ga 68 Dotatate · Uihc Pet Imaging · Oncology
2019 — Vyleesi (Autoinjector) · Cosette · Neuroscience
2019 — Rozlytrek · Roche · Oncology
2019 — Inrebic · Bristol-Myers Squibb · Oncology
2019 — Reblozyl · Celgene Corp · Hematology
2019 — PEFICITINIB
2019 — Guna-Geriatrics · Bracco · Nephrology
2019 — BETIBEGLOGENE AUTOTEMCEL
2019 — SOLRIAMFETOL HYDROCHLORIDE
2019 — ENFORTUMAB VEDOTIN
2019 — Accrufer · Shield Tx · Hematology
2019 — Recarbrio · Merck & Co. · Infectious Disease
2019 — PEXIDARTINIB HYDROCHLORIDE
2019 — TRIFAROTENE
2019 — Trecondi · Medexus · Oncology
2019 — Xcopri · Sk Life · Neuroscience
2019 — Tissueblue · Dutch Ophthalmic · Ophthalmology
2019 — Xenleta · Hong Kong · Infectious Disease
2019 — Padcev · Astellas Pharma · Oncology
2019 — SIPONIMOD FUMARIC ACID
2019 — Reyvow · Eli Lilly · Neuroscience
2019 — Levoamlodipine · Cardiovascular
2019 — Skyrizi · AbbVie · Immunology
2019 — Caplyta · Intra-Cellular · Neuroscience
2019 — Zulresso · Sage Therap · Neuroscience
2019 — TENAPANOR
2019 — AMLODIPINE BENZOATE
2019 — Selg1 · Novartis · Metabolic
2019 — Oxbryta · Global Blood Theraps · Hematology
2019 — Egaten · Novartis · Infectious Disease
2019 — Spravato · Johnson & Johnson · Metabolic
2019 — Polivy · Roche · Oncology
2019 — Wakix · Harmony · Neuroscience
2019 — Mayzent · Novartis · Neuroscience
2019 — Ubrelvy · AbbVie · Neuroscience
2019 — UPADACITINIB HEMIHYDRATE
2019 — Truseltiq · Helsinn Hlthcare · Oncology
2019 — Vyondys 53 · Sarepta · Rare Disease
2019 — Inrebic · Bristol-Myers Squibb · Oncology
2019 — Enfortumab · Astellas Pharma · Oncology
2019 — Dayvigo · Eisai · Neuroscience
2019 — Piqray · Novartis · Oncology
2019 — Vyndaqel · Foldrx Pharms · Neuroscience
2019 — Nourianz · Kyowa Kirin · Neuroscience
2019 — Scenesse · Clivunel Inc · Rare Disease
2019 — Brukinsa · Beigene Usa Inc · Oncology
2019 — Slynd · Exeltis Usa Inc · Dermatology
2019 — Balversa · Johnson & Johnson · Oncology
2019 — Nubeqa · Bayer · Oncology
2019 — Xerava · Tetraphase Pharms · Infectious Disease
2019 — olmesartan medoxomil-hydrochlorothiazide · Cosette · Metabolic
2019 — Beovu · Novartis · Metabolic
2019 — Calibvi · Ablynx Nv · Metabolic
2019 — PEXIDARTINIB
2019 — Givlaari · Alnylam Pharmaceuticals · Neuroscience
2019 — Fetroja · Shionogi · Infectious Disease
2019 — ENTRECTINIB
2019 — LEVAMLODIPINE MALEATE
2019 — TENAPANOR HYDROCHLORIDE
2019 — Sterile Water · Pfizer
2019 — Padcev Ejfv · Astellas Pharma · Oncology

Patent expiries (0)

No entries tracked.

Phase 3 readouts (0)

No entries tracked.